Well, I do enjoy a new preclinical indication announcement by Recce!
I get to update my list of indications they have announced / worked on / abandoned:
- bioweapons
- burns
- ABSSSI
- DFI
- DFU
- cancer
- H pylori
- sepsis
- uro sepsis
- pneumonia
- COVID
- mycobacterium
- hamsters
- gonorrhea
- sinus infections
- influenza
- lung infections
I can't imagine what's next. If I were to guess, and this is pure speculation.... I think they will announce they are pivoting to animals. Closing the circle and returning us back to Chemeq v2.0! Wouldn't that be something.
Ann: Recce Enters into USA Department of Defense R&D Agreement, page-21
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.005(1.69%) |
Mkt cap ! $86.51M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 29.0¢ | $37.22K | 127.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8471 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 17050 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |